Encephalitis explained Types of encephalitis Infectious encephalitis Measles infection and encephalitis Download PDF Measles infection and encephalitis By Dr Natasha Crowcroft, Consultant Medical Epidemiologist and reviewed by Dr Sylviane Defres, Institute of Infection and Global Health, University of Liverpool and Dean Walton, Core medical trainee 2 (CMT2), Whiston Hospital, UK Measles infection and encephalitis Encephalitis can occur in children either during or after a measles infection. This can happen as a result of the brain becoming infected with the virus during the rash phase of the illness or by an immune-mediated brain inflammation subsequent to measles infection. Measles is also the cause of a disease called subacute sclerosing panencephalitis (SSPE). This is a rare condition that can develop years after natural measles infection. SSPE is a degenerative neurological condition which progressively destroys nerve cells in the brain and almost always leads to mental deterioration and death. More information on SSPE is available on our website www.encephalitis.info. Measles, mumps and rubella (MMR) vaccine The MMR vaccine is a very effective way to prevent against measles, mumps and rubella. These infections are important causes of encephalitis, and before MMR vaccine was introduced all three infections were common in the UK. There is a wide range of credible information available on the good safety record of MMR vaccine at www.gov.uk/government/uploads/system/uploads/attachment_data/file/147968/Green-Book-Chapter-21-v2_0.pdf It is clear that the vaccine is safer than letting children catch the diseases. The example below compares the risk of measles with the risk of MMR vaccine. Measles 1-3 in 1,000 children contracting measles will develop encephalitis concurrent with the measles infection. 10–15% of those children will die and a further 25% of patients will be left with permanent neurological damage. 1 in 1,000 children with measles will develop post-infectious encephalitis. 1 in 25,000 of children (1 in 5,500 children if they are under 1) with measles will develop subacute sclerosing panencephalitis (SSPE) which has a fatal (death) outcome. 1-2 in 1.000.000 children who had vaccination will develop encephalitis from the vaccination which is less than the incidence of all types of encephalitis. In the past decade, coverage of measles, mumps and rubella vaccination in the UK has not been high enough. Many countries across Europe are currently experiencing large epidemics of measles as a result of not enough children having the MMR vaccine. In 2013, outbreaks of measles were reported in the North-West of England (376 cases) and Swansea (664 cases). Acute encephalitis contributed to two of three measles related deaths reported in Europe in 2012. This highlights how important it is to make sure that children are protected from this preventable disease. d. For information on encephalitis and its effects, please see our information on what is encephalitis and recovery after encephalitis. Further Reading Measles encephalitis caused the death of Roald Dahl’s daughter, Olivia, in 1962. He became an ardent supporter of measles vaccination as a result of the tragic loss of his daughter. He wrote a letter to parents encouraging them to get their children vaccinate Roald Dahl's letter to parents A blog by Dr Ava Easton, CEO of the Encephalitis Society, about measles vaccines and encephalitis. An article by Dr Ava Easton, CEO of the Encephalitis Society -"Measles catching your death" looking at measles- diagnosis, treatment, complications, prevention, vaccination and travel health. First publication in Practice Nurse in January 2022. Reproduced with kind permission of Practice Nurse. FEEDBACK What do you think about this information? Please leave us your feedback If you have found this information helpful, please consider making a donation to help us continue our life-saving work in the future. Make a Donation FS043V4 Measles infection and encephalitis Date created: May 2006; Last updated: June 2020; Review date: June 2023 Disclaimer: We try to ensure that the information is easy to understand, accurate and up-to-date as possible. If you would like more information on the source material the author used to write this document please contact the Encephalitis Society. None of the authors of the above document has declared any conflict of interest which may arise from being named as an author of this document.